Evidence map›Paper›PMID 25070856›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

Essential role for the lectin pathway in collagen antibody-induced arthritis revealed through use of adenovirus programming complement inhibitor MAp44 expression.

Nirmal K Banda, Gaurav Mehta, Troels R Kjaer, Minoru Takahashi, Jerome Schaack, Thomas E Morrison, Steffen Thiel, William P Arend, V Michael Holers

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 36 citations in OpenAlex.

  1. Trial
  2. Article
  3. Get Spliced: Uniting Alternative Splicing and Arthritis.International journal of molecular sciences · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Combining MAP-1:CD35 or MAP-1:CD55 fusion proteins with pattern-recognition molecules as novel targeted modulators of the complement cascade.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Nirmal K BandaDivision of Rheumatology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO 80045; Nirmal.Banda@ucdenver.edu Michael.Holers@ucdenver.edu.
Gaurav MehtaDivision of Rheumatology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO 80045;
Troels R KjaerDepartment of Biomedicine, Aarhus University, DK-8000 Aarhus C, Denmark;
Minoru TakahashiDepartment of Immunology, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan; and.
Jerome SchaackDepartment of Microbiology, University of Colorado School of Medicine, Aurora, CO 80045.
Thomas E MorrisonDepartment of Microbiology, University of Colorado School of Medicine, Aurora, CO 80045.
Steffen ThielDepartment of Biomedicine, Aarhus University, DK-8000 Aarhus C, Denmark;
William P ArendDivision of Rheumatology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO 80045;
V Michael HolersDivision of Rheumatology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO 80045; Nirmal.Banda@ucdenver.edu Michael.Holers@ucdenver.edu.
University of Colorado Denver · USAarhus University · DKAarhus University Hospital · DKFukushima Medical University · JP

Funding

Complement in the Pathogenesis of Autoimmune ArthritisR01AR051749 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI Vernon Michael Holers · 2004 to 2026
$6.7M
Complement in the Pathogenesis of Autoimmune ArthritisR56AR051749 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI HOLERS, VERNON MICHAEL · 2020 to 2020
$342k
NIAMS NIH HHS AR051749NIAMS NIH HHS R01 AR051749NIAMS NIH HHS R56 AR051749
6 · The paper itself

Abstract

Previous studies using mannose-binding lectin (MBL) and complement C4-deficient mice have suggested that the lectin pathway (LP) is not required for the development of inflammatory arthritis in the collagen Ab-induced arthritis (CAIA) model. MBL, ficolins and collectin-11 are key LP pattern recognition molecules that associate with three serine proteases-MASP-1, MASP-2, and MASP-3-and with two MBL-associated proteins designated sMAP and MBL-associated protein of 44kDA (MAp44). Recent studies have shown that MAp44, an alternatively spliced product of the MASP-1/3 gene, is a competitive inhibitor of the binding of the recognition molecules to all three MASPs. In these studies, we examined the effect of treatment of mice with adenovirus (Ad) programmed to express human MAp44 (AdhMAp44) on the development of CAIA. AdhMAp44 and Ad programming GFP (AdGFP) expression were injected i.p. in C57BL/6 wild type mice prior to the induction of CAIA. AdhMAp44 significantly reduced the clinical disease activity (CDA) score by 81% compared with mice injected with AdGFP. Similarly, histopathologic injury scores for inflammation, pannus, cartilage and bone damage, as well as C3 deposition in the cartilage and synovium, were significantly reduced by AdhMAp44 pretreatment. Mice treated with AdmMAp44, programming expression of mouse MAp44, also showed significantly decreased CDA score and histopathologic injury scores. In addition, administration of AdhMAp44 significantly diminished the severity of Ross River virus-induced arthritis, an LP-dependent model. Our study provides conclusive evidence that an intact complement LP is essential to initiate CAIA, and that MAp44 may be an appropriate treatment for inflammatory arthritis.

Indexed as

AdenoviridaeAlphavirus InfectionsAlternative SplicingAnimalsArthritis, ExperimentalComplement C3Complement Pathway, Mannose-Binding LectinHumansMannose-Binding Protein-Associated Serine ProteasesMiceMice, KnockoutRoss River virusTransduction, GeneticComplement C3Mannose-Binding Protein-Associated Serine ProteasesMASP-1 protein, mouse

Identifiers

PMID25070856
PMCPMC4134985
OpenAlexW2111957028

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.